Articles with "preclinical data" as a keyword



Photo by diana_pole from unsplash

Is preclinical data sharing the new norm?

Sign Up to like & get
recommendations!
Published in 2018 at "Drug discovery today"

DOI: 10.1016/j.drudis.2016.05.003

Abstract: Is preclinical data sharing the new norm? In my experience, it is certainly becoming more commonplace. However, it is not yet standard practice and remains the preserve of special projects. Here, I expound the benefits… read more here.

Keywords: new norm; data sharing; preclinical data; sharing new ... See more keywords
Photo from wikipedia

Checkpoint inhibitors in ovarian cancer: A review of preclinical data

Sign Up to like & get
recommendations!
Published in 2019 at "Gynecologic Oncology Reports"

DOI: 10.1016/j.gore.2019.06.003

Abstract: Ovarian cancer is the deadliest gynecologic malignancy, and relapse after initial treatment is frequently fatal. Although ovarian cancer typically has an immunosuppressive tumor microenvironment, a strong intratumoral T cell presence is associated with an improved… read more here.

Keywords: checkpoint inhibitors; use; ovarian cancer; cancer ... See more keywords
Photo from wikipedia

Abstract 5566: LYC-55716, a first-in-class RORγ agonist: Rationale and preclinical data to support clinical combinations with established immunotherapies

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer Research"

DOI: 10.1158/1538-7445.am2018-5566

Abstract: The retinoic acid-related orphan receptor γt (RORγt) is a nuclear receptor transcription factor that acts as an immune cell master control switch driving the generation and function of Th17 (helper) and Tc17 (cytotoxic) T cells.… read more here.

Keywords: clinical combinations; ror; ror agonist; lyc 55716 ... See more keywords
Photo from wikipedia

Gene Therapy Vector Encoding Neuropeptide Y and Its Receptor Y2 for Future Treatment of Epilepsy: Preclinical Data in Rats

Sign Up to like & get
recommendations!
Published in 2020 at "Frontiers in Molecular Neuroscience"

DOI: 10.3389/fnmol.2020.603409

Abstract: Gene therapy to treat pharmacoresistant temporal lobe epilepsy in humans is now being developed using an AAV vector (CG01) that encodes the combination of neuropeptide Y and its antiepileptic receptor Y2. With this in mind,… read more here.

Keywords: vector; cg01; gene therapy; preclinical data ... See more keywords